1vcl

From Proteopedia

(Difference between revisions)

Current revision

Crystal Structure of Hemolytic Lectin CEL-III

Structural highlights

1vcl is a 2 chain structure with sequence from Cucumaria echinata. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance.
Method:	X-ray diffraction, Resolution 1.7Å
Ligands:	, , , ,
Resources:	FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT

Function

CEL3_CUCEC Galactose/N-acetylgalactosamine (Gal/GalNAc)-binding lectin with hemolytic activity. Favors saccharides that have a beta-1,4 linkage at the non-reducing end rather than saccharides having alpha-1,6 or alpha-1,4 linkages. Binds lactose, lactulose, GalNAc, galactosamine, methyl alpha-galactopyranoside, methyl beta-galactopyranoside, N-acetyllactosamine, p-nitrophenyl beta-D-galactopyranoside (pNP-Gal), p-nitrophenyl N-acetyl-beta-D-galactosaminide (pNP-GalNAc), asialofetuin, and human erythrocyte membrane lipids lactosyl ceramide (LacCer) and globoside globotetraosylceramide (Gb4Cer). Binds moderately to galactose, melibiose, raffinose, fucose, methyl alpha-galactoside and methyl beta-galactoside. Binds weakly to glucose, mannose and N-acetylglucosamine (GlcNAc) (PubMed:10101284, PubMed:10478454, PubMed:10923802, PubMed:11471734, PubMed:11983084, PubMed:14561725, PubMed:15194688, PubMed:17977832, PubMed:18159942, PubMed:19356139, PubMed:19420692, PubMed:22313748, PubMed:23470749, PubMed:23545649, PubMed:23583369, PubMed:24652284, PubMed:27101707, PubMed:7798179, PubMed:7876091, PubMed:8663224, PubMed:9058193, PubMed:9133626, PubMed:9305736, PubMed:9692203, PubMed:9805377, PubMed:9990124). Has hemolytic activity towards human (A, B and O-type), rabbit and rat erythrocytes, but not towards mouse, chicken or horse erythrocytes (PubMed:10101284, PubMed:10923802, PubMed:11471734, PubMed:18159942, PubMed:19356139, PubMed:19420692, PubMed:22313748, PubMed:23583369, PubMed:27101707, PubMed:7798179, PubMed:7876091, PubMed:8663224, PubMed:9058193, PubMed:9692203, PubMed:9805377). Forms ion-permeable transmembrane pores in the erythrocyte membrane as well as in artificial liposomes containing human erythrocyte membrane lipids LacCer, Gb4Cer and galactosyl ceramide (GalCer) leading to destruction of the membrane (PubMed:10478454, PubMed:7876091, PubMed:9133626, PubMed:9990124). Has hemagglutinating activity towards rabbit, human and rat erythrocytes, and at relatively high concentrations towards chicken and horse erythrocytes, but not towards mouse erythrocytes (PubMed:10923802, PubMed:11471734, PubMed:14561725, PubMed:18159942, PubMed:19420692, PubMed:7798179, PubMed:9692203, PubMed:9805377, PubMed:9990124). Has dose-dependent cytotoxic effect on Madin-Darby canine kidney (MDCK), African green monkey kidney (Vero) and human epithelia carcinoma (HeLa) cell lines, but Chinese hamster ovary (CHO), rat sarcoma (XC) and potoroo rat kangaroo kidney (PtK1) cells are highly resistant to the cytotoxic effect of this protein (PubMed:10101284, PubMed:9133626). Impairs malaria parasite development in malaria parasite infected transgenic A.stephensi mosquitoes expressing this protein specifically in their midguts. Binds to ookinetes and leads to strong dose-dependent inhibition of ookinete formation in vitro. Leads to severely impaired oocyst formation and significantly reduced sporozoite production of rodent malaria parasite P.berghei in the salivary glands of the transgenic mosquitoes. The parasite transmission to uninfected mice (vectorial competence) of these mosquitoes is significantly impaired. Leads also to severely impaired oocyst formation of human malaria parasite P.falciparum in transgenic mosquitoes fed on mature P.falciparum gametocyte cultures (PubMed:18159942). May be involved in defense mechanisms acting as a toxic protein to foreign microorganisms (PubMed:7876091, PubMed:9133626). May act in defense against predators (PubMed:24652284).^[1] ^[2] ^[3] ^[4] ^[5] ^[6] ^[7] ^[8] ^[9] ^[10] ^[11] ^[12] ^[13] ^[14] ^[15] ^[16] ^[17] ^[18] ^[19] ^[20] ^[21] ^[22] ^[23] ^[24] ^[25] ^[26]

Evolutionary Conservation

Check, as determined by ConSurfDB. You may read the explanation of the method and the full data available from ConSurf.

Publication Abstract from PubMed

CEL-III is a Ca(2+)-dependent and galactose-specific lectin purified from the sea cucumber, Cucumaria echinata, which exhibits hemolytic and hemagglutinating activities. Six molecules of CEL-III are assumed to oligomerize to form an ion-permeable pore in the cell membrane. We have determined the crystal structure of CELIII by using single isomorphous replacement aided by anomalous scattering in lead at 1.7 A resolution. CEL-III consists of three distinct domains as follows: the N-terminal two carbohydrate-binding domains (1 and 2), which adopt beta-trefoil folds such as the B-chain of ricin and are members of the (QXW)(3) motif family; and domain 3, which is a novel fold composed of two alpha-helices and one beta-sandwich. CEL-III is the first Ca(2+)-dependent lectin structure with two beta-trefoil folds. Despite sharing the structure of the B-chain of ricin, CEL-III binds five Ca(2+) ions at five of the six subdomains in both domains 1 and 2. Considering the relatively high similarity among the five subdomains, they are putative binding sites for galactose-related carbohydrates, although it remains to be elucidated whether bound Ca(2+) is directly involved in interaction with carbohydrates. The paucity of hydrophobic interactions in the interfaces between the domains and biochemical data suggest that these domains rearrange upon carbohydrate binding in the erythrocyte membrane. This conformational change may be responsible for oligomerization of CEL-III molecules and hemolysis in the erythrocyte membranes.

Crystal structure of the hemolytic lectin CEL-III isolated from the marine invertebrate Cucumaria echinata: implications of domain structure for its membrane pore-formation mechanism.,Uchida T, Yamasaki T, Eto S, Sugawara H, Kurisu G, Nakagawa A, Kusunoki M, Hatakeyama T J Biol Chem. 2004 Aug 27;279(35):37133-41. Epub 2004 Jun 11. PMID:15194688^[27]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

References

↑ Oda T, Shinmura N, Nishioka Y, Komatsu N, Hatakeyama T, Muramatsu T. Effect of the hemolytic lectin CEL-III from Holothuroidea Cucumaria echinata on the ANS fluorescence responses in sensitive MDCK and resistant CHO cells. J Biochem. 1999 Apr;125(4):713-20. PMID:10101284 doi:10.1093/oxfordjournals.jbchem.a022341
↑ Kouriki-Nagatomo H, Hatakeyama T, Jelokhani-Niaraki M, Kondo M, Ehara T, Yamasaki N. Molecular mechanism for pore-formation in lipid membranes by the hemolytic lectin CEL-III from marine invertebrate Cucumaria echinata. Biosci Biotechnol Biochem. 1999 Jul;63(7):1279-84. PMID:10478454 doi:10.1271/bbb.63.1279
↑ Kuwahara H, Funada T, Hatakeyama T, Aoyagi H. Effects of chemical modification of carboxyl groups in the hemolytic lectin CEL-III on its hemolytic and carbohydrate-binding activities. Biosci Biotechnol Biochem. 2000 Jun;64(6):1278-81. PMID:10923802 doi:10.1271/bbb.64.1278
↑ Sallay I, Tojo S, Nomiyama K, Kouzuma Y, Kimura M, Yamasaki N. Calcium ions stabilize a protein structure of hemolytic lectin CEL-III from marine invertebrate Cucumaria echinata. Biosci Biotechnol Biochem. 2001 Jun;65(6):1347-52. PMID:11471734 doi:10.1271/bbb.65.1347
↑ Kuwahara H, Yamasaki T, Hatakeyama T, Aoyagi H, Fujisawa T. Oligomerization process of the hemolytic lectin CEL-III purified from a sea cucumber, Cucumaria echinata. J Biochem. 2002 May;131(5):751-6. PMID:11983084 doi:10.1093/oxfordjournals.jbchem.a003161
↑ Kouzuma Y, Suzuki Y, Nakano M, Matsuyama K, Tojo S, Kimura M, Yamasaki T, Aoyagi H, Hatakeyama T. Characterization of functional domains of the hemolytic lectin CEL-III from the marine invertebrate Cucumaria echinata. J Biochem. 2003 Sep;134(3):395-402. PMID:14561725 doi:10.1093/jb/mvg157
↑ Uchida T, Yamasaki T, Eto S, Sugawara H, Kurisu G, Nakagawa A, Kusunoki M, Hatakeyama T. Crystal structure of the hemolytic lectin CEL-III isolated from the marine invertebrate Cucumaria echinata: implications of domain structure for its membrane pore-formation mechanism. J Biol Chem. 2004 Aug 27;279(35):37133-41. Epub 2004 Jun 11. PMID:15194688 doi:10.1074/jbc.M404065200
↑ Hatakeyama T, Unno H, Kouzuma Y, Uchida T, Eto S, Hidemura H, Kato N, Yonekura M, Kusunoki M. C-type lectin-like carbohydrate recognition of the hemolytic lectin CEL-III containing ricin-type -trefoil folds. J Biol Chem. 2007 Dec 28;282(52):37826-35. Epub 2007 Oct 31. PMID:17977832 doi:http://dx.doi.org/10.1074/jbc.M705604200
↑ Yoshida S, Shimada Y, Kondoh D, Kouzuma Y, Ghosh AK, Jacobs-Lorena M, Sinden RE. Hemolytic C-type lectin CEL-III from sea cucumber expressed in transgenic mosquitoes impairs malaria parasite development. PLoS Pathog. 2007 Dec;3(12):e192. PMID:18159942 doi:10.1371/journal.ppat.0030192
↑ Hisamatsu K, Unno H, Goda S, Hatakeyama T. Roles of the valine clusters in domain 3 of the hemolytic lectin CEL-III in its oligomerization and hemolytic abilities. Protein Pept Lett. 2009;16(4):411-4. PMID:19356139 doi:10.2174/092986609787848054
↑ Hisamatsu K, Unno H, Goda S, Hatakeyama T. Effects of Ca2+ on refolding of the recombinant hemolytic lectin CEL-III. Biosci Biotechnol Biochem. 2009 May;73(5):1203-5. PMID:19420692 doi:10.1271/bbb.80793
↑ Shimizu Y, Yamazaki H, Yoshida S, Yonekura M, Kouzuma Y. Molecular cloning, functional expression, and characterization of isolectin genes of hemolytic lectin CEL-III from the marine invertebrate Cucumaria echinata. Biosci Biotechnol Biochem. 2012;76(2):276-82. PMID:22313748 doi:10.1271/bbb.110635
↑ Goda S, Sadakata H, Unno H, Hatakeyama T. Effects of detergents on the oligomeric structures of hemolytic lectin CEL-III as determined by small-angle X-ray scattering. Biosci Biotechnol Biochem. 2013;77(3):679-81. PMID:23470749 doi:10.1271/bbb.120981
↑ Unno H, Hisamatsu K, Nagao T, Tateya Y, Matsumoto N, Goda S, Hatakeyama T. Crystallization and preliminary crystallographic study of oligomers of the haemolytic lectin CEL-III from the sea cucumber Cucumaria echinata. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013 Apr 1;69(Pt 4):416-20. PMID:23545649 doi:10.1107/S1744309113004065
↑ Hisamatsu K, Nagao T, Unno H, Goda S, Hatakeyama T. Identification of the amino acid residues involved in the hemolytic activity of the Cucumaria echinata lectin CEL-III. Biochim Biophys Acta. 2013 Aug;1830(8):4211-7. PMID:23583369 doi:10.1016/j.bbagen.2013.04.010
↑ Unno H, Goda S, Hatakeyama T. Hemolytic lectin CEL-III heptamerizes via a large structural transition from α-helices to a β-barrel during the transmembrane pore formation process. J Biol Chem. 2014 May 2;289(18):12805-12. PMID:24652284 doi:10.1074/jbc.M113.541896
↑ Nagao T, Masaki R, Unno H, Goda S, Hatakeyama T. Effects of amino acid mutations in the pore-forming domain of the hemolytic lectin CEL-III. Biosci Biotechnol Biochem. 2016 Oct;80(10):1966-9. PMID:27101707 doi:10.1080/09168451.2016.1176520
↑ Hatakeyama T, Kohzaki H, Nagatomo H, Yamasaki N. Purification and characterization of four Ca(2+)-dependent lectins from the marine invertebrate, Cucumaria echinata. J Biochem. 1994 Jul;116(1):209-14. PMID:7798179 doi:10.1093/oxfordjournals.jbchem.a124495
↑ Hatakeyama T, Nagatomo H, Yamasaki N. Interaction of the hemolytic lectin CEL-III from the marine invertebrate Cucumaria echinata with the erythrocyte membrane. J Biol Chem. 1995 Feb 24;270(8):3560-4. PMID:7876091 doi:10.1074/jbc.270.8.3560
↑ Hatakeyama T, Furukawa M, Nagatomo H, Yamasaki N, Mori T. Oligomerization of the hemolytic lectin CEL-III from the marine invertebrate Cucumaria echinata induced by the binding of carbohydrate ligands. J Biol Chem. 1996 Jul 12;271(28):16915-20. PMID:8663224 doi:10.1074/jbc.271.28.16915
↑ Hatakeyama T, Miyamoto Y, Nagatomo H, Sallay I, Yamasaki N. Carbohydrate-binding properties of the hemolytic lectin CEL-III from the holothuroidea Cucumaria echinata as analyzed using carbohydrate-coated microplate. J Biochem. 1997 Jan;121(1):63-7. PMID:9058193 doi:10.1093/oxfordjournals.jbchem.a021571
↑ Oda T, Tsuru M, Hatakeyama T, Nagatomo H, Muramatsu T, Yamasaki N. Temperature from the marine invertebrate Cucumaria echinata on various cell lines. J Biochem. 1997 Mar;121(3):560-7. PMID:9133626 doi:10.1093/oxfordjournals.jbchem.a021622
↑ Fujisawa T, Kuwahara H, Hiromasa Y, Niidome T, Aoyagi H, Hatakeyama T. Small-angle X-ray scattering study on CEL-III, a hemolytic lectin from Holothuroidea Cucumaria echinata, and its oligomer induced by the binding of specific carbohydrate. FEBS Lett. 1997 Sep 1;414(1):79-83. PMID:9305736 doi:10.1016/s0014-5793(97)00976-9
↑ Hatakeyama T, Matsuyama Y, Funada T, Fukuyama S, Kuwahara H, Aoyagi H, Yamasaki N. Chemical modification of the hemolytic lectin CEL-III by succinic anhydride: involvement of amino groups in the oligomerization process. Biosci Biotechnol Biochem. 1998 Jun;62(6):1185-9. PMID:9692203 doi:10.1271/bbb.62.1185
↑ Sallay I, Hatakeyama T, Yamasaki N. Studies on the carbohydrate binding sites of the hemolytic lectin CEL-III isolated from the marine invertebrate Cucumaria echinata. Biosci Biotechnol Biochem. 1998 Sep;62(9):1757-61. PMID:9805377 doi:10.1271/bbb.62.1757
↑ Hatakeyama T, Sato T, Taira E, Kuwahara H, Niidome T, Aoyagi H. Characterization of the interaction of hemolytic lectin CEL-III from the marine invertebrate, Cucumaria echinata, with artificial lipid membranes: involvement of neutral sphingoglycolipids in the pore-forming process. J Biochem. 1999 Feb;125(2):277-84. PMID:9990124 doi:10.1093/oxfordjournals.jbchem.a022284
↑ Uchida T, Yamasaki T, Eto S, Sugawara H, Kurisu G, Nakagawa A, Kusunoki M, Hatakeyama T. Crystal structure of the hemolytic lectin CEL-III isolated from the marine invertebrate Cucumaria echinata: implications of domain structure for its membrane pore-formation mechanism. J Biol Chem. 2004 Aug 27;279(35):37133-41. Epub 2004 Jun 11. PMID:15194688 doi:10.1074/jbc.M404065200

1 Structural highlights
2 Function
3 Evolutionary Conservation
4 Publication Abstract from PubMed
5 References

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1vcl"

@@ Line 4: / Line 4: @@
 == Structural highlights ==
 <table><tr><td colspan='2'>[[1vcl]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Cucumaria_echinata Cucumaria echinata]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1VCL OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1VCL FirstGlance]. <br>
-</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BTB:2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL'>BTB</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene></td></tr>
+</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.7&#8491;</td></tr>
-<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=PCA:PYROGLUTAMIC+ACID'>PCA</scene></td></tr>
+<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BTB:2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL'>BTB</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=PCA:PYROGLUTAMIC+ACID'>PCA</scene></td></tr>
 <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1vcl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1vcl OCA], [https://pdbe.org/1vcl PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1vcl RCSB], [https://www.ebi.ac.uk/pdbsum/1vcl PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1vcl ProSAT]</span></td></tr>
 </table>
+== Function ==
+[https://www.uniprot.org/uniprot/CEL3_CUCEC CEL3_CUCEC] Galactose/N-acetylgalactosamine (Gal/GalNAc)-binding lectin with hemolytic activity. Favors saccharides that have a beta-1,4 linkage at the non-reducing end rather than saccharides having alpha-1,6 or alpha-1,4 linkages. Binds lactose, lactulose, GalNAc, galactosamine, methyl alpha-galactopyranoside, methyl beta-galactopyranoside, N-acetyllactosamine, p-nitrophenyl beta-D-galactopyranoside (pNP-Gal), p-nitrophenyl N-acetyl-beta-D-galactosaminide (pNP-GalNAc), asialofetuin, and human erythrocyte membrane lipids lactosyl ceramide (LacCer) and globoside globotetraosylceramide (Gb4Cer). Binds moderately to galactose, melibiose, raffinose, fucose, methyl alpha-galactoside and methyl beta-galactoside. Binds weakly to glucose, mannose and N-acetylglucosamine (GlcNAc) (PubMed:10101284, PubMed:10478454, PubMed:10923802, PubMed:11471734, PubMed:11983084, PubMed:14561725, PubMed:15194688, PubMed:17977832, PubMed:18159942, PubMed:19356139, PubMed:19420692, PubMed:22313748, PubMed:23470749, PubMed:23545649, PubMed:23583369, PubMed:24652284, PubMed:27101707, PubMed:7798179, PubMed:7876091, PubMed:8663224, PubMed:9058193, PubMed:9133626, PubMed:9305736, PubMed:9692203, PubMed:9805377, PubMed:9990124). Has hemolytic activity towards human (A, B and O-type), rabbit and rat erythrocytes, but not towards mouse, chicken or horse erythrocytes (PubMed:10101284, PubMed:10923802, PubMed:11471734, PubMed:18159942, PubMed:19356139, PubMed:19420692, PubMed:22313748, PubMed:23583369, PubMed:27101707, PubMed:7798179, PubMed:7876091, PubMed:8663224, PubMed:9058193, PubMed:9692203, PubMed:9805377). Forms ion-permeable transmembrane pores in the erythrocyte membrane as well as in artificial liposomes containing human erythrocyte membrane lipids LacCer, Gb4Cer and galactosyl ceramide (GalCer) leading to destruction of the membrane (PubMed:10478454, PubMed:7876091, PubMed:9133626, PubMed:9990124). Has hemagglutinating activity towards rabbit, human and rat erythrocytes, and at relatively high concentrations towards chicken and horse erythrocytes, but not towards mouse erythrocytes (PubMed:10923802, PubMed:11471734, PubMed:14561725, PubMed:18159942, PubMed:19420692, PubMed:7798179, PubMed:9692203, PubMed:9805377, PubMed:9990124). Has dose-dependent cytotoxic effect on Madin-Darby canine kidney (MDCK), African green monkey kidney (Vero) and human epithelia carcinoma (HeLa) cell lines, but Chinese hamster ovary (CHO), rat sarcoma (XC) and potoroo rat kangaroo kidney (PtK1) cells are highly resistant to the cytotoxic effect of this protein (PubMed:10101284, PubMed:9133626). Impairs malaria parasite development in malaria parasite infected transgenic A.stephensi mosquitoes expressing this protein specifically in their midguts. Binds to ookinetes and leads to strong dose-dependent inhibition of ookinete formation in vitro. Leads to severely impaired oocyst formation and significantly reduced sporozoite production of rodent malaria parasite P.berghei in the salivary glands of the transgenic mosquitoes. The parasite transmission to uninfected mice (vectorial competence) of these mosquitoes is significantly impaired. Leads also to severely impaired oocyst formation of human malaria parasite P.falciparum in transgenic mosquitoes fed on mature P.falciparum gametocyte cultures (PubMed:18159942). May be involved in defense mechanisms acting as a toxic protein to foreign microorganisms (PubMed:7876091, PubMed:9133626). May act in defense against predators (PubMed:24652284).<ref>PMID:10101284</ref> <ref>PMID:10478454</ref> <ref>PMID:10923802</ref> <ref>PMID:11471734</ref> <ref>PMID:11983084</ref> <ref>PMID:14561725</ref> <ref>PMID:15194688</ref> <ref>PMID:17977832</ref> <ref>PMID:18159942</ref> <ref>PMID:19356139</ref> <ref>PMID:19420692</ref> <ref>PMID:22313748</ref> <ref>PMID:23470749</ref> <ref>PMID:23545649</ref> <ref>PMID:23583369</ref> <ref>PMID:24652284</ref> <ref>PMID:27101707</ref> <ref>PMID:7798179</ref> <ref>PMID:7876091</ref> <ref>PMID:8663224</ref> <ref>PMID:9058193</ref> <ref>PMID:9133626</ref> <ref>PMID:9305736</ref> <ref>PMID:9692203</ref> <ref>PMID:9805377</ref> <ref>PMID:9990124</ref>
 == Evolutionary Conservation ==
 [[Image:Consurf_key_small.gif|200px|right]]
@@ Line 13: / Line 15: @@
   <jmolCheckbox>
     <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/vc/1vcl_consurf.spt"</scriptWhenChecked>
-    <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked>
+    <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview03.spt</scriptWhenUnchecked>
     <text>to colour the structure by Evolutionary Conservation</text>
   </jmolCheckbox>
@@ Line 33: / Line 35: @@
 [[Category: Cucumaria echinata]]
 [[Category: Large Structures]]
-[[Category: Eto, S]]
+[[Category: Eto S]]
-[[Category: Hatakeyama, T]]
+[[Category: Hatakeyama T]]
-[[Category: Kurisu, G]]
+[[Category: Kurisu G]]
-[[Category: Kusunoki, M]]
+[[Category: Kusunoki M]]
-[[Category: Nakagawa, A]]
+[[Category: Nakagawa A]]
-[[Category: Sugawara, H]]
+[[Category: Sugawara H]]
-[[Category: Uchida, T]]
+[[Category: Uchida T]]
-[[Category: Yamasaki, T]]
+[[Category: Yamasaki T]]
-[[Category: Calcium]]
-[[Category: Cel-iii]]
-[[Category: Hemagglutination]]
-[[Category: Hemolysis]]
-[[Category: Lectin]]
-[[Category: Pore-forming]]
-[[Category: Toxin]]

1vcl

From Proteopedia

Current revision

Crystal Structure of Hemolytic Lectin CEL-III

Structural highlights

Function

Evolutionary Conservation

Publication Abstract from PubMed

References

Contents

Proteopedia Page Contributors and Editors (what is this?)

Views

Personal tools

Navigation

Search

Toolbox